Isolation and identification of bioactive compounds from Antrodia camphorata against ESKAPE pathogens.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
04
2023
accepted:
10
10
2023
medline:
30
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
epublish
Résumé
Antimicrobial resistance is a major threat to human health globally. Antrodia camphorata was grown in a malt/yeast extract broth liquid medium for 15 days. Then, 4-L fermentation broth was harvested, yielding 7.13 g of the ethyl acetate extract. By tracing the antimicrobial activity, 12.22 mg of the antimicrobial compound was isolated. The structure of 5-methyl-benzo [1,3]-dioxole-4,7-diol (MBBD) was elucidated using NMR and MS data analyses. The antibacterial activity of MBBD was detected through the microbroth dilution method. MBBD exhibited broad-spectrum antibacterial activity. The minimum inhibitory concentration (MIC) range of MBBD for drug-resistant pathogenic bacteria was 64-256 μg/mL, with the lowest MIC observed for Acinetobacter baumannii (64 μg/mL), followed by Pseudomonas aeruginosa (MIC = 128 μg/mL). Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, and Escherichia coli were also sensitive, with an MIC of 256 μg/mL. The MIC range of MBBD against 10 foodborne pathogens was 12.5-100 μg/mL. Based on the results of this study, MBBD exhibits broad-spectrum antibacterial activity, particularly demonstrating excellent inhibitory effects against A. baumannii. MBBD will be good candidates for new antimicrobial drugs.
Identifiants
pubmed: 37889913
doi: 10.1371/journal.pone.0293361
pii: PONE-D-23-11914
pmc: PMC10610075
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0293361Informations de copyright
Copyright: © 2023 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Sci Rep. 2016 Apr 22;6:24748
pubmed: 27103062
BMC Complement Altern Med. 2018 Sep 26;18(1):261
pubmed: 30257662
PLoS One. 2014 Aug 21;9(8):e105286
pubmed: 25144619
J Ethnopharmacol. 2009 Jun 25;123(3):494-8
pubmed: 19481384
Antibiotics (Basel). 2019 Mar 14;8(1):
pubmed: 30875778
Int J Obes (Lond). 2018 Feb;42(2):231-243
pubmed: 28630461
J Fungi (Basel). 2021 Oct 31;7(11):
pubmed: 34829215
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
EMBO Rep. 2020 Dec 3;21(12):e51034
pubmed: 33400359
Mycobiology. 2022 Apr 21;50(2):121-131
pubmed: 35571860
Front Immunol. 2021 May 14;12:664425
pubmed: 34054833
Drugs. 2019 Feb;79(3):271-289
pubmed: 30712199
FEMS Microbiol Lett. 2014 Sep;358(1):36-43
pubmed: 25053476
Phytother Res. 2009 Apr;23(4):582-4
pubmed: 19003946
J Antimicrob Chemother. 2019 Jul 1;74(7):1971-1974
pubmed: 31220260
PeerJ. 2020 Aug 11;8:e9543
pubmed: 32864203
Lancet Infect Dis. 2018 Dec;18(12):1319-1328
pubmed: 30509675
Saudi J Biol Sci. 2023 Mar;30(3):103582
pubmed: 36852413
Org Biomol Chem. 2012 Sep 21;10(35):7220-6
pubmed: 22847560
Int J Mol Sci. 2020 Nov 12;21(22):
pubmed: 33198306
J Antibiot (Tokyo). 2019 Oct;72(10):752-758
pubmed: 31324892
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Evid Based Complement Alternat Med. 2011;2011:984027
pubmed: 19293251
Chin J Nat Med. 2020 Apr;18(4):261-267
pubmed: 32402402
World J Clin Cases. 2014 Dec 16;2(12):787-814
pubmed: 25516853
Clin Microbiol Rev. 2020 May 13;33(3):
pubmed: 32404435
Adv Drug Deliv Rev. 2022 Feb;181:114078
pubmed: 34896131
PLoS One. 2019 Jun 27;14(6):e0217627
pubmed: 31247016
Microorganisms. 2021 Jan 19;9(1):
pubmed: 33477910
Nat Prod Res. 2011 Sep;25(16):1488-96
pubmed: 21337253
Nat Prod Res. 2022 Oct;36(19):4982-4989
pubmed: 33902349
J Cell Mol Med. 2020 Jan;24(1):50-60
pubmed: 31568643
Nat Prod Rep. 2021 Jan 1;38(1):83-102
pubmed: 32720965
Biotechnol Appl Biochem. 2016 May;63(3):398-406
pubmed: 25906825
Front Microbiol. 2019 Apr 01;10:539
pubmed: 30988669
Prev Nutr Food Sci. 2021 Mar 31;26(1):58-66
pubmed: 33859960
J Ind Microbiol Biotechnol. 2022 Jan 20;49(1):
pubmed: 34791342
Microb Drug Resist. 2021 Aug;27(8):1105-1116
pubmed: 33439767